NaturImmun

NATURAL KILLER CELL-BASED ANTI-CANCER IMMUNOTHERAPIES

The Natural Killer Cell-Based Anti-Cancer Immunotherapies - NATURIMMUN - project is a Marie Curie Initial Training Network funded by the EC 7th Framework Program. The network started in October 2012 and will run over 4 years.

The main goal of this network is to generate new knowledge on the molecular mechanisms of innate immune responses against tumor and virally infected cells focusing on natural killer (NK) and NKT cells. It aims to translate the findings into the development of cell-based technologies and reagents for the treatment of cancer and viral infections. As part of a Marie Curie program, the project will also focus on the promotion and recognition of excellence in European research, therefore we will highlight the personal achievements of our fellows with a view to supporting their further development and international recognition.

NATURIMMUN is formed by 11 groups located in 7 countries. All principal investigators of the project are renown scientists in the field of NK cells and the consortium also includes 3 biotech companies. Ten Early Stage Researchers (ESR or PhD students) and three Experienced Researchers (ER or postdocs) were selected after a very selective fellow assessment to participate in this ambitious project.

 

Learn more

 

Call Identifier: FP7-PEOPLE-2012-ITN-317013
Grant Agreement Number: 317013